Navigation Links
Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers

AMSTERDAM, November 30 /PRNewswire-FirstCall/ -- Elsevier, the world's leading publisher of scientific, medical and technical products and services, today announced a major re-launch of Embase, its comprehensive biomedical database which holds over 20 million indexed records from more than 7,000 active, peer reviewed journals.

Embase has long played a key role in the advancement of new biomedical and pharmaceutical insights. Now, new developments and updates include:

    - Enabling all biomedical researchers to use Embase --
      extending its "usability" from information specialists to also include
      all biomedical and pharmaceutical scientists, and clinical and
      regulatory professionals.

    - New retrieval tools that further drive discovery, including
      quick and easy refining of search results and the display of indexed
      drug-drug and drug-disease relations.

    - Improved comprehensiveness through the addition of indexed
      articles-in-press and conference abstracts.

    - To signify the enhanced focus on biomedical answers, the
      product has a new, fresh look and feel to it.

Thomas Gutjahr, Head of the Knowledge Center at Actelion Pharmaceuticals Ltd., comments: "I'm very impressed by all the new improvements which I believe will greatly help with pin-pointing certain searches, e.g. drug-drug interactions or drug-disease searches."

Embase supports researchers with key tasks such as tracking of drug adverse events, comparing drug therapies, and Evidence Based Medicine research. It provides researchers with deep insights and understanding from the world's life sciences information, enabling effective discoveries towards medical discovery and treatment.


Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet ( and Cell (, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (, Scopus (, Reaxys (, MD Consult ( and Nursing Consult (, which enhance the productivity of science and health professionals, and the SciVal suite ( and MEDai's Pinpoint Review (, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contacts:

    Tom Reller

    Emma Potter
    Kaizo PR

SOURCE Elsevier

SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ScienceDirect to Host French-Language Journals from Elsevier Masson
2. Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
3. Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps
4. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
5. Elsevier and the Association of Southeast Asian Institutions
6. Elseviers Partners With QUOSA
7. Elsevier Announces Winners of 3rd Annual Scopus Young Indian Scientist Award
8. Elsevier Introduces The American Journal of Medicine Blog
9. Elsevier Introduces Breakthrough Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
10. The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books
11. Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. ... STACS DNA as a Field Application Specialist. , “I am thrilled that Dr. ... STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings a ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
(Date:6/23/2016)... 2016 adds 2016 ... its pharmaceuticals section with historic and forecast data ... more. Complete report on the Cell ... 15 companies and supported with 261 tables and ... . The Global Cell Culture Media ...
Breaking Biology Technology:
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):